Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lily Liu

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
BMC Cancer|April 17, 2015
A novel engineered VEGF blocker with an excellent pharmacokinetic profile and robust anti-tumor activityLily Liu, Haijia Yu, Xin Huang, et al.
Frontiers in Immunology|November 13, 2018
Modulation of Antibody Responses to the V1V2 and V3 Regions of HIV-1 Envelope by Immune Complex VaccinesCatarina E Hioe, Rajnish Kumar, Chitra Upadhyay, et al.
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|November 3, 2012
Fine genetic mapping of RXopJ4, a bacterial spot disease resistance locus from Solanum pennellii LA716Molly Sharlach, Douglas Dahlbeck, Lily Liu, et al.
Virology|January 22, 2019
Anti-V2 antibody deficiency in individuals infected with HIV-1 in CameroonLily Liu, Liuzhe Li, Aubin Nanfack, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2006
Phase II study of belagenpumatucel-L, a transforming growth factor beta-2 antisense gene-modified allogeneic tumor cell vaccine in non-small-cell lung cancerJohn Nemunaitis, Robert O Dillman, Paul O Schwarzenberger, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 18, 2022
Characterization of an Anti-CD70 Half-Life Extended Bispecific T-Cell Engager (HLE-BiTE) and Associated On-Target Toxicity in Cynomolgus MonkeysTod Harper, Amy Sharma, Sarav Kaliyaperumal, et al.
Vaccine|February 11, 2017
Differential induction of anti-V3 crown antibodies with cradle- and ladle-binding modes in response to HIV-1 envelope vaccinationPreetha Balasubramanian, Rajnish Kumar, Constance Williams, et al.
Molecular and Cellular Endocrinology|February 14, 2013
Activation of FFA1 mediates GLP-1 secretion in mice. Evidence for allosterism at FFA1Yumei Xiong, Gayathri Swaminath, Qiong Cao, et al.
Molecular Cancer Therapeutics|February 15, 2014
Preclinical evaluation of AMG 925, a FLT3/CDK4 dual kinase inhibitor for treating acute myeloid leukemiaKathleen Keegan, Cong Li, Zhihong Li, et al.
Neuro-Oncology Advances|June 16, 2023
WSD-0922, a novel brain-penetrant inhibitor of epidermal growth factor receptor, promotes survival in glioblastoma mouse modelsJason E Conage-Pough, Sylwia A Stopka, Ju-Hee Oh, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
BMC Cancer|April 17, 2015
A novel engineered VEGF blocker with an excellent pharmacokinetic profile and robust anti-tumor activityLily Liu, Haijia Yu, Xin Huang, et al.
Frontiers in Immunology|November 13, 2018
Modulation of Antibody Responses to the V1V2 and V3 Regions of HIV-1 Envelope by Immune Complex VaccinesCatarina E Hioe, Rajnish Kumar, Chitra Upadhyay, et al.
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|November 3, 2012
Fine genetic mapping of RXopJ4, a bacterial spot disease resistance locus from Solanum pennellii LA716Molly Sharlach, Douglas Dahlbeck, Lily Liu, et al.
Virology|January 22, 2019
Anti-V2 antibody deficiency in individuals infected with HIV-1 in CameroonLily Liu, Liuzhe Li, Aubin Nanfack, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2006
Phase II study of belagenpumatucel-L, a transforming growth factor beta-2 antisense gene-modified allogeneic tumor cell vaccine in non-small-cell lung cancerJohn Nemunaitis, Robert O Dillman, Paul O Schwarzenberger, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 18, 2022
Characterization of an Anti-CD70 Half-Life Extended Bispecific T-Cell Engager (HLE-BiTE) and Associated On-Target Toxicity in Cynomolgus MonkeysTod Harper, Amy Sharma, Sarav Kaliyaperumal, et al.
Vaccine|February 11, 2017
Differential induction of anti-V3 crown antibodies with cradle- and ladle-binding modes in response to HIV-1 envelope vaccinationPreetha Balasubramanian, Rajnish Kumar, Constance Williams, et al.
Molecular and Cellular Endocrinology|February 14, 2013
Activation of FFA1 mediates GLP-1 secretion in mice. Evidence for allosterism at FFA1Yumei Xiong, Gayathri Swaminath, Qiong Cao, et al.
Molecular Cancer Therapeutics|February 15, 2014
Preclinical evaluation of AMG 925, a FLT3/CDK4 dual kinase inhibitor for treating acute myeloid leukemiaKathleen Keegan, Cong Li, Zhihong Li, et al.
Neuro-Oncology Advances|June 16, 2023
WSD-0922, a novel brain-penetrant inhibitor of epidermal growth factor receptor, promotes survival in glioblastoma mouse modelsJason E Conage-Pough, Sylwia A Stopka, Ju-Hee Oh, et al.
Pageof 5